NO20034560L - Middel for topisk oftalmisk behandling av okul¶re inflammasjonssykdommer - Google Patents

Middel for topisk oftalmisk behandling av okul¶re inflammasjonssykdommer

Info

Publication number
NO20034560L
NO20034560L NO20034560A NO20034560A NO20034560L NO 20034560 L NO20034560 L NO 20034560L NO 20034560 A NO20034560 A NO 20034560A NO 20034560 A NO20034560 A NO 20034560A NO 20034560 L NO20034560 L NO 20034560L
Authority
NO
Norway
Prior art keywords
remedy
inflammatory diseases
topical ophthalmic
ocular inflammatory
ophthalmic treatment
Prior art date
Application number
NO20034560A
Other languages
English (en)
Norwegian (no)
Other versions
NO20034560D0 (no
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of NO20034560D0 publication Critical patent/NO20034560D0/no
Publication of NO20034560L publication Critical patent/NO20034560L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
NO20034560A 2001-04-12 2003-10-10 Middel for topisk oftalmisk behandling av okul¶re inflammasjonssykdommer NO20034560L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28316901P 2001-04-12 2001-04-12
PCT/JP2002/003664 WO2002085359A1 (en) 2001-04-12 2002-04-12 Agent for topical ophthalmic treatment of ocular inflammatory diseases

Publications (2)

Publication Number Publication Date
NO20034560D0 NO20034560D0 (no) 2003-10-10
NO20034560L true NO20034560L (no) 2003-12-09

Family

ID=23084835

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034560A NO20034560L (no) 2001-04-12 2003-10-10 Middel for topisk oftalmisk behandling av okul¶re inflammasjonssykdommer

Country Status (12)

Country Link
US (1) US20020187998A1 (OSRAM)
EP (1) EP1379247A1 (OSRAM)
JP (1) JP2004529928A (OSRAM)
KR (1) KR20040007494A (OSRAM)
CN (1) CN1503671A (OSRAM)
AR (1) AR033151A1 (OSRAM)
BR (1) BR0208939A (OSRAM)
CA (1) CA2445508A1 (OSRAM)
MX (1) MXPA03009273A (OSRAM)
NO (1) NO20034560L (OSRAM)
NZ (1) NZ529255A (OSRAM)
WO (1) WO2002085359A1 (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033604B2 (en) * 2001-07-06 2006-04-25 Sucampo Ag Composition for topical administration
IL161849A0 (en) * 2001-11-19 2005-11-20 Novartis Ag Use of an ascomycin for the treatment of blepharitis
AU2003256068A1 (en) * 2002-08-09 2004-02-25 Sucampo Pharmaceuticals, Inc. Pharmaceutical compositions comprising fk506 derivatives and the ir use for the treatment of allergic diseases
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
WO2004062669A1 (en) * 2003-01-16 2004-07-29 Sucampo Ag Use of a macrolide compound for treating dry eye
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
US7083802B2 (en) 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
AU2004274026A1 (en) 2003-09-18 2005-03-31 Macusight, Inc. Transscleral delivery
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
US7087237B2 (en) * 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
US20060258698A1 (en) 2005-02-09 2006-11-16 Sreenivasu Mudumba Liquid formulations for treatment of diseases or conditions
BRPI0707612B8 (pt) 2006-02-09 2021-05-25 Macusight Inc vaso lacrado e formulações líquidas contidas no mesmo
EP2001466B1 (en) 2006-03-23 2016-01-06 Santen Pharmaceutical Co., Ltd Low-dose rapamycin for the treatment of vascular permeability-related diseases
US8536190B2 (en) * 2007-01-30 2013-09-17 Allergan, Inc. Treating unwanted ocular conditions using an ascomycin macrolactam
US20170198026A1 (en) * 2014-06-06 2017-07-13 The Schepens Eye Research Institute, Inc. Compositions And Methods For Treating Tumors And Immune Based Inflammatory Diseases
HUE048564T2 (hu) * 2015-01-26 2020-08-28 Bausch & Lomb Szemészeti szuszpenzió készítmény
KR101710412B1 (ko) 2015-09-15 2017-02-27 인제대학교 산학협력단 Ycg063을 유효성분으로 함유하는 염증성 안구질환 예방 또는 치료용 약학조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
DE69016515T2 (de) * 1989-07-05 1995-06-08 Fujisawa Pharmaceutical Co Wässriges flüssiges Mittel zur äusserlichen Anwendung.
DE10299040I2 (de) * 1989-11-09 2006-08-24 Novartis Ag Heteroatome enthaltende tricyclische Verbindungen
IE65341B1 (en) * 1990-11-08 1995-10-18 Fujisawa Pharmaceutical Co Suspensions containing tricyclic compounds
CA2102241C (en) * 1991-04-26 2003-12-30 Manabu Mochizuki Use of macrolide compounds for eye diseases
AR004480A1 (es) * 1995-04-06 1998-12-16 Amico Derin C D Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen

Also Published As

Publication number Publication date
EP1379247A1 (en) 2004-01-14
NZ529255A (en) 2006-09-29
WO2002085359A1 (en) 2002-10-31
CN1503671A (zh) 2004-06-09
US20020187998A1 (en) 2002-12-12
BR0208939A (pt) 2004-04-20
KR20040007494A (ko) 2004-01-24
MXPA03009273A (es) 2004-02-12
AR033151A1 (es) 2003-12-03
JP2004529928A (ja) 2004-09-30
NO20034560D0 (no) 2003-10-10
CA2445508A1 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
NO20034560D0 (no) Middel for topisk oftalmisk behandling av okul¶re inflammasjonssykdommer
IS7215A (is) Aðferðir til að meðhöndla nýæðarsjúkdóma í augum
ATE374196T1 (de) Dihydrobenzodiazepin-2-on-derivative für die behandlung von neurologischen erkrankungen
DE60233414D1 (de) Kombinationen für die behandlung entzündlicher erkrankungen
ATE441417T1 (de) Benzoädüazepinderivate für die behandlung von neurologischen krankheiten
NO20031442D0 (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
EP1646614A4 (en) OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF OCCULAR HYPERTONIA
NO20044450L (no) Kombinasjon av brimonidine og timolol for topisk oftalmisk anvendelse
DE60226702D1 (de) Lang wirkendes glucagon-ähnliches peptid-2 für die behandlung von gastrointestinalen krankheiten und störungen
DZ3500A1 (fr) Derives de phenethanolamine pour le traitement de maladies respiratoires
NO20031443L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
ATE478864T1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
EP1732484A4 (en) OPHTHALMIC IMPLANT FOR THE TREATMENT OF GLAUCOMA
NO20026008D0 (no) Fremgangsmåte for behandling av cardiovaskul¶re sykdommer
DE60239558D1 (de) Kombinationen für die behandlung von immun-entzündlichen erkrankungen
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
NO20052751D0 (no) Oftalmisk preparat for behandling av okulaer hypertensjon.
EP1664011A4 (en) OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF OCCULAR HYPERTONIA
EP1594435A4 (en) INHIBITION OF HIV-1 REPLICATION BY TREATMENT OF THE PROCESSING OF THE VIRAL CAPSID-SPACER PEPTIDE 1 PROTEIN
ATE330596T1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
EP1646381A4 (en) COMBINATION THERAPY FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES
NO20035043D0 (no) Fremgangsmåte for behandling av okular hypertensjon og glaukom
IL144949A0 (en) Treatment of prion diseases with dmso
DE60120961D1 (de) Disulfid-derivate verwendbar zur behandlung von allergischen erkrankungen
NO20032006D0 (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application